[go: up one dir, main page]

ATE378328T1 - Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung - Google Patents

Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung

Info

Publication number
ATE378328T1
ATE378328T1 AT02712114T AT02712114T ATE378328T1 AT E378328 T1 ATE378328 T1 AT E378328T1 AT 02712114 T AT02712114 T AT 02712114T AT 02712114 T AT02712114 T AT 02712114T AT E378328 T1 ATE378328 T1 AT E378328T1
Authority
AT
Austria
Prior art keywords
pyrrolo
prodrugs
indole
tumor treatment
quinoline derivatives
Prior art date
Application number
AT02712114T
Other languages
English (en)
Inventor
Mark Searcey
L Patterson
Original Assignee
Univ London Pharmacy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London Pharmacy filed Critical Univ London Pharmacy
Application granted granted Critical
Publication of ATE378328T1 publication Critical patent/ATE378328T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
AT02712114T 2001-02-22 2002-02-22 Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung ATE378328T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01301636 2001-02-22

Publications (1)

Publication Number Publication Date
ATE378328T1 true ATE378328T1 (de) 2007-11-15

Family

ID=8181737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02712114T ATE378328T1 (de) 2001-02-22 2002-02-22 Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung

Country Status (7)

Country Link
US (1) US7626026B2 (de)
EP (1) EP1409480B1 (de)
JP (1) JP2004529887A (de)
AT (1) ATE378328T1 (de)
DE (1) DE60223544T2 (de)
ES (1) ES2299560T3 (de)
WO (1) WO2002068412A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE327750T1 (de) * 2001-02-22 2006-06-15 Univ London Pharmacy Benz-indol- und benzo-chinolin-derivate als prodrugs zur tumorbehandlung
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
GB0505644D0 (en) 2005-03-18 2005-04-27 Univ London Pharmacy Analogues of the azinomycins as anti-tumour agents and as prodrugs
MX2009006877A (es) 2006-12-22 2009-09-28 Schering Corp Derivados indolicos con anillo unido en las posiciones 5,6 y metodos de uso de los mismos.
EP2064180B1 (de) 2006-12-22 2016-07-13 Merck Sharp & Dohme Corp. 4,5-ring-annulierte indol-derivate zur behandlung oder prävention von hcv und verwandten virusinfektionen
EP2064181A1 (de) * 2006-12-22 2009-06-03 Schering Corporation 4,5-ring-annulierte indol-derivate zur behandlung oder prävention von hcv und verwandten virusinfektionen
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
EP2197842B1 (de) 2007-08-29 2012-05-23 Schering Corporation 2,3-substituierte indolderivate zur behandlung von virusinfektionen
CN101842374A (zh) 2007-08-29 2010-09-22 先灵公司 用于治疗病毒感染的2，3-取代的氮杂吲哚衍生物
AU2008295484B2 (en) 2007-08-29 2013-09-26 Merck Sharp & Dohme Llc Substituted indole derivatives and methods of use thereof
US8765757B2 (en) 2007-11-16 2014-07-01 Merck Sharp & Dohme Corp. 3-heterocyclic substituted indole derivatives and methods of use thereof
CN102317285A (zh) 2007-11-16 2012-01-11 先灵公司 3-氨基磺酰基取代的吲哚衍生物及其使用方法
CA2727620A1 (en) 2008-06-13 2009-12-17 Schering Corporation Tricyclic indole derivatives and methods of use thereof
MX2011004625A (es) 2008-11-03 2011-07-20 Syntarga Bv Analogos cc-1065 novedosos y sus conjugados.
AU2011243294C1 (en) 2010-04-21 2015-12-03 Syntarga B.V. Novel conjugates of CC-1065 analogs and bifunctional linkers
US8496218B2 (en) * 2011-06-08 2013-07-30 Alcon Research, Ltd. Display monitor guide
PT3092010T (pt) 2014-01-10 2018-09-28 Synthon Biopharmaceuticals Bv Método para purificação de conjugados anticorpo-fármaco ligados por cys
GB202300668D0 (en) * 2023-01-17 2023-03-01 Univ Bradford Cancer treating compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
EP0244120A3 (de) 1986-04-16 1989-07-12 Courtaulds Plc Element aus Verbundwerkstoff
FI85403C (fi) 1989-12-22 1992-04-10 Neste Oy Foerfarande foer framstaellning av en plastkompositbalk eller -pelare med staolfoerstaerkningen.
ES2149768T3 (es) 1992-03-25 2000-11-16 Immunogen Inc Conjugados de agentes enlazantes de celulas derivados de cc-1065.
FR2700805B1 (fr) 1993-01-27 1995-04-07 Ind Entreprise Procédé de renforcement d'une poutre détériorée, et poutre ainsi obtenue.
US5448869A (en) 1994-02-17 1995-09-12 Marvin Lumber And Cedar Co. Composite framing member and window or door assembly incorporating a composite framing member
US5501054A (en) 1994-03-01 1996-03-26 The United States Of America As Represented By The Secretary Of Agriculture Bolted wood connections
US5720143A (en) 1994-03-01 1998-02-24 The United States Of America As Represented By The Secretary Of Agriculture Localized notch reinforcement for wooden beams
US5679432A (en) 1994-05-09 1997-10-21 Benchmark Foam, Inc. Multi-layer laminate structure
US5688426A (en) 1995-06-07 1997-11-18 The Boeing Company Hybrid metal webbed composite beam
US5657595A (en) 1995-06-29 1997-08-19 Hexcel-Fyfe Co., L.L.C. Fabric reinforced beam and column connections
GB9519490D0 (en) 1995-09-25 1995-11-29 Melvin William T Use of a cytochrome P450 enzyme in tumour cells as a marker and target
ES2244991T3 (es) 1996-03-08 2005-12-16 The Scripps Research Institute Analogosmcbi de cc-1065 y las duocarmicinas.
US5843937A (en) * 1996-05-23 1998-12-01 Panorama Research, Inc. DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
US6060608A (en) 1996-05-31 2000-05-09 The Scripps Research Institute Analogs of CC-1065 and the duocarmycins
US5794402A (en) 1996-09-30 1998-08-18 Martin Marietta Materials, Inc. Modular polymer matrix composite support structure and methods of constructing same
WO1998052925A1 (en) * 1997-05-22 1998-11-26 The Scripps Research Institute Analogs of duocarmycin and cc-1065
WO1999040056A1 (en) 1998-02-06 1999-08-12 De Montfort University Hydroxylation activated prodrugs

Also Published As

Publication number Publication date
DE60223544D1 (de) 2007-12-27
JP2004529887A (ja) 2004-09-30
DE60223544T2 (de) 2008-09-25
EP1409480B1 (de) 2007-11-14
EP1409480A1 (de) 2004-04-21
WO2002068412A1 (en) 2002-09-06
US7626026B2 (en) 2009-12-01
US20040157873A1 (en) 2004-08-12
ES2299560T3 (es) 2008-06-01

Similar Documents

Publication Publication Date Title
ATE378328T1 (de) Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung
ATE327750T1 (de) Benz-indol- und benzo-chinolin-derivate als prodrugs zur tumorbehandlung
DE60220057D1 (de) Indoline und tetrahydro-chinoline als prodrugs zur tumorbehandlung
PT2420234E (pt) 1h-benzimidazole-4-carboxamidas substituídas com um carbono quaternário na posição 2 como inibidores de parp para uso no tratamento do cancro
HK1216545A1 (zh) 用於誘導外顯子跳躍的反義寡核苷酸及其使用方法
WO2006084017A3 (en) Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
MX2009013341A (es) Derivados de 6-(pirrolopiridinil)-pirimidinil-2-amina.
SG164368A1 (en) Treatment of cancer
WO2004062613A3 (en) Hiv integrase inhibitors
MY157715A (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
TW200722079A (en) Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
NZ580226A (en) Dimer compounds as inhibitors of iap
TW200726753A (en) 2,4-diamino-pyrimidines as aurora inhibitors
MX2009006864A (es) Inhibidores novedosos de c jun-n-terminal cinasas.
WO2010003475A3 (de) Neue pyrrolidinderivate als metap-2 inhibitoren
TW200720271A (en) DNA-PK inhibitors
HK1104290A1 (en) Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents
WO2010000364A8 (de) Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate
MX2007003470A (es) Compuestos de carbonilo los cuales pueden utilizarse como inhibidores del factor de coagulacion xa.
WO2007120333A3 (en) Tetracyclic kinase inhibitors
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
MY148644A (en) New pharmaceutical compounds
WO2003063787A3 (en) Non-steroidal analogs of 2-methoxyestradiol
WO2006124996A3 (en) Inhibitors of polo-like kinase-1
WO2008152306A3 (fr) Nouveaux substrats de peptidase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties